GTF2A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.842000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.770600E-01
Normal-vs-Stage2
7.803800E-01
Normal-vs-Stage3
1.263220E-01
Normal-vs-Stage4
3.800600E-01
Stage1-vs-Stage2
8.429800E-01
Stage1-vs-Stage3
3.503700E-02
Stage1-vs-Stage4
2.907600E-01
Stage2-vs-Stage3
1.305750E-01
Stage2-vs-Stage4
2.547000E-01
Stage3-vs-Stage4
1.157580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.498800E-01
Normal-vs-AfricanAmerican
7.905400E-01
Normal-vs-Asian
5.747600E-01
Caucasian-vs-AfricanAmerican
3.377000E-01
Caucasian-vs-Asian
4.017400E-01
AfricanAmerican-vs-Asian
2.974200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.178400E-01
Normal-vs-Female
8.553800E-01
Male-vs-Female
6.639800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.991800E-01
Normal-vs-Age(41-60Yrs)
9.010400E-01
Normal-vs-Age(61-80Yrs)
6.587400E-01
Normal-vs-Age(81-100Yrs)
3.050800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.383400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.776200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.255200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.183500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.602500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.788800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.609600E-01
Normal-vs-Daily Drinker
3.952600E-01
Normal-vs-Weekly Drinker
5.539600E-01
Normal-vs-Occasional Drinker
8.254600E-01
Normal-vs-Social Drinker
8.480600E-01
Non Drinker-vs-Daily Drinker
6.748200E-01
Non Drinker-vs-Weekly Drinker
9.299800E-01
Non Drinker-vs-Occasional Drinker
6.620300E-02
Non Drinker-vs-Social Drinker
1.673950E-01
Daily Drinker-vs-Weekly Drinker
6.837200E-01
Daily Drinker-vs-Occasional Drinker
5.180000E-02
Daily Drinker-vs-Social Drinker
8.782100E-02
Weekly Drinker-vs-Occasional Drinker
1.750840E-01
Weekly Drinker-vs-Social Drinker
2.386600E-01
Occasional Drinker-vs-Social Drinker
9.864000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.634000E-01
Normal-vs-Grade 2
1.536780E-01
Normal-vs-Grade 3
1.044180E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.776800E-01
Grade 1-vs-Grade 3
2.186000E-01
Grade 1-vs-Grade 4
2.634000E-01
Grade 2-vs-Grade 3
2.216000E-01
Grade 2-vs-Grade 4
1.536780E-01
Grade 3-vs-Grade 4
1.044180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.251600E-01
Normal-vs-NonDiabetic
5.977800E-01
Diabetic-vs-NonDiabetic
8.856200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.014200E-01
Normal-vs-NoPancreatitis
7.057000E-01
Pancreatitis-vs-NoPancreatitis
1.352320E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.936400E-01
Normal-vs-N1
8.045800E-01
N0-vs-N1
8.674600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.158600E-01
Normal-vs-TP53-NonMutant
9.988400E-01
TP53-Mutant-vs-TP53-NonMutant
3.921800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
